Trial · NCT01708629
Adverse events232
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 232
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | 210 mg Brodalumab | 31 | 624 | |
| other | Nasopharyngitis | Infections and infestations | 140 mg Brodalumab | 36 | 629 | |
| other | Nasopharyngitis | Infections and infestations | Placebo | 22 | 315 | |
| other | Nasopharyngitis | Infections and infestations | Ustekinumab | 16 | 313 | |
| other | Upper respiratory tract Infection | Infections and infestations | 210 mg Brodalumab | 33 | 624 | |
| other | Upper respiratory tract Infection | Infections and infestations | 140 mg Brodalumab | 19 | 629 | |
| other | Upper respiratory tract Infection | Infections and infestations | Placebo | 17 | 315 | |
| other | Upper respiratory tract Infection | Infections and infestations | Ustekinumab | 16 | 313 | |
| other | Urinary Tract Infection | Infections and infestations | 210 mg Brodalumab | 11 | 624 | |
| other | Urinary Tract Infection | Infections and infestations | 140 mg Brodalumab | 5 | 629 | |
| other | Urinary Tract Infection | Infections and infestations | Placebo | 3 | 315 | |
| other | Urinary Tract Infection | Infections and infestations | Ustekinumab | 8 | 313 | |
| other | Pharyngitis | Infections and infestations | 210 mg Brodalumab | 9 | 624 | |
| other | Pharyngitis | Infections and infestations | 140 mg Brodalumab | 5 | 629 | |
| other | Pharyngitis | Infections and infestations | Placebo | 6 | 315 | |
| other | Pharyngitis | Infections and infestations | Ustekinumab | 4 | 313 | |
| other | Influenza | Infections and infestations | 210 mg Brodalumab | 8 | 624 | |
| other | Influenza | Infections and infestations | 140 mg Brodalumab | 5 | 629 | |
| other | Influenza | Infections and infestations | Placebo | 2 | 315 | |
| other | Influenza | Infections and infestations | Ustekinumab | 6 | 313 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01708629/events